Effective treatment of polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes syndrome with congestive heart failure: A case report

Table 1 Laboratory findings on admission

Hematology	Serum chemistry	Endocrinology
WBC (7.71 × 109/L)	α1 (8.5%)	LH (0.02 mIU/mL)
Neu (65.4%)	γ (30.9%)	FSH (0.95 mIU/mL)
RBC (2.88 × 1012 /L)	Alb (22 g/L)	GH (11.69 ng/mL)
HB (85 g/dL)	cTnT (0.188 μg/L)	T3 (0.54 nmol/L)
Hct (28%)	Mb (272.8 ng/mL)	T4 (5.26 nmol/L)
PLT (360 × 109/L)	CK-MB (12.7 U/L)	TSH (17.634 mU/L)
	BNP (5487 pg/mL)	PTH (51.6 ng/L)
Urinalysis	PT (16.5 s)	IGF-1 (< 25.0 ng/mL)
	PTR (1.43)	VEGF (9800 pg/mL)
Protein (1921 μmol/dL)	INR (1.45)	IgG (23.90 g/L)
M protein (0.27 g/L)	Fbg (3.95 g/L)	IgA (5.04 g/L)
KET (++)	ALB (26 g/L)	HbA1c (8.10%)
	AST (30 U/L)
	ALT (25 U/L)
	BUN (7.4 mmol/L)
	CRE (50 μmol/L)
	UA (408 μmol/L)
	Na (135 mmol/L)
	K (4.8 mmol/L)
	Cl (104 mmol/L)

WBC: White blood cells; ALB: Albumin; AST: Aspartate aminotransferase; ALT: Alanine aminotransferase; INR: International normalized ratio; VEGF: Vascular endothelial-derived growth factor; IgG: Immunoglobulin G; IgA: Immunoglobulin A; HbA1c: Hemoglobin A1c; IGF-1: Insulin-like growth factor 1; RBC: Red blood cells; CK-MB: Creatine kinase MB; BNP: Brain natriuretic peptide; FSH: Follicle-stimulating hormone; TSH: Thyroid Stimulating Hormone; PTH: Parathyroid hormone; PT: Prothrombin time.